Original Article: Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.
作者信息
Soni Mamta
机构信息
Apollo Hospitals, Chennai, India.
出版信息
Int J Lab Hematol. 2021 Dec;43(6):e303. doi: 10.1111/ijlh.13573. Epub 2021 May 11.
Abstract
摘要
相似文献
1
Original Article: Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.原创文章：评估嗜酸性粒细胞减少作为新型冠状病毒肺炎感染的诊断和预后指标
Int J Lab Hematol. 2021 Dec;43(6):e303. doi: 10.1111/ijlh.13573. Epub 2021 May 11.
2
Original article: Soni M. Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection. Int J Lab Hematol. 2020;00:1-5. https://doi.org/10.1111/ijlh.13425.原始文章：索尼·M. 嗜酸性粒细胞减少作为新冠病毒感染的诊断和预后指标的评估。《国际实验室血液学杂志》。2020年；00:1 - 5。https://doi.org/10.1111/ijlh.13425 。
Int J Lab Hematol. 2021 Dec;43(6):e287-e289. doi: 10.1111/ijlh.13572. Epub 2021 May 11.
3
Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.评价嗜酸性粒细胞减少症作为 COVID-19 感染的诊断和预后指标。
Int J Lab Hematol. 2021 Jul;43 Suppl 1:137-141. doi: 10.1111/ijlh.13425. Epub 2020 Dec 8.
4
A study to evaluate the role of eosinophil count as a prognostic marker for assessing the outcome in patients with COVID 19 infection.一项评估嗜酸性粒细胞计数作为 COVID-19 感染患者预后评估标志物的作用的研究。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
5
Eosinopenia <100/μL as a marker of active COVID-19: An observational prospective study.嗜酸性粒细胞计数 <100/μL 作为 COVID-19 活动期的标志物：一项观察性前瞻性研究。
J Microbiol Immunol Infect. 2021 Feb;54(1):61-68. doi: 10.1016/j.jmii.2020.12.005. Epub 2021 Jan 8.
6
Eosinopenia in COVID-19: What we missed so far?新冠病毒肺炎中的嗜酸性粒细胞减少症：我们目前遗漏了什么？
J Microbiol Immunol Infect. 2021 Oct;54(5):1006-1007. doi: 10.1016/j.jmii.2021.01.013. Epub 2021 Feb 18.
7
EOSINOPENIA: an early, effective and relevant COVID-19 biomarker?嗜酸性粒细胞减少：一种早期、有效的新冠病毒相关生物标志物？
QJM. 2021 Feb 18;114(1):68-69. doi: 10.1093/qjmed/hcaa259.
8
Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019.嗜酸性粒细胞减少可能是2019冠状病毒病患者的一个相关预后生物标志物。
Allergy Asthma Proc. 2020 Nov 1;41(6):e80-e82. doi: 10.2500/aap.2020.41.200079.
9
Association of eosinopenia with worsening prognosis in hospitalized Azvudine-treated COVID-19 patients: a retrospective cohort study.中性粒细胞减少与住院阿兹夫定治疗的 COVID-19 患者预后恶化相关：一项回顾性队列研究。
Front Immunol. 2023 Dec 15;14:1320973. doi: 10.3389/fimmu.2023.1320973. eCollection 2023.
10
Eosinopenia is a reliable marker of severe disease and unfavourable outcome in patients with COVID-19 pneumonia.嗜酸性粒细胞减少症是 COVID-19 肺炎患者严重疾病和不良预后的可靠标志物。
Int J Clin Pract. 2021 Jul;75(7):e14047. doi: 10.1111/ijcp.14047. Epub 2021 Feb 5.
引用本文的文献
1
Eosinopenia as Predictor of Poor Outcome in Hospitalized COVID-19 Adult Patients from Waves 1 and 2 of 2020 Pandemic.嗜酸性粒细胞减少作为2020年大流行第1波和第2波住院COVID-19成年患者不良预后的预测指标。
Microorganisms. 2022 Dec 7;10(12):2423. doi: 10.3390/microorganisms10122423.
Zotero 插件